Anticoagulation in COVID-19

Lancet. 2022 Jan 1;399(10319):5-7. doi: 10.1016/S0140-6736(21)02503-4. Epub 2021 Dec 15.

Authors

Charlotte A Bradbury¹, Zoe McQuilten²

Affiliations

¹ Bristol Haematology and Oncology Centre, University of Bristol, Bristol BS2 8ED, UK. Electronic address: c.bradbury@bristol.ac.uk.
² Department of Epidemiology and Preventive Medicine, Monash University, Melbourne, VIC, Australia; Clinical Haematology, Monash Health, Melbourne, VIC, Australia.

No abstract available

Publication types

Comment

MeSH terms

Anticoagulants / adverse effects
Blood Coagulation / drug effects
COVID-19*
Humans
SARS-CoV-2

Substances

Anticoagulants